Wednesday, March 27, 2013 5:58:16 PM
(JNS.org) Israel’s Oramed Pharmaceuticals is on the brink of developing a new oral insulin pill that could revolutionize Type 2 diabetes treatment, Israel21c reported.
The pill, which would replace the current method of self-injecting insulin, mimics insulin’s natural location and gradients by first passing through the liver before entering the bloodstream. It could help an estimated 371 million people worldwide who are affected by Type 2 diabetes.
Oramed was founded in 2006 by Dr. Miram Kidron, based on her 25 years of research on diabetes at Jerusalem’s Hadassah Media Center. Her son Nadav Kidron is the president and CEO of the company. The insulin pill is designed to target adult diabetics who are not yet insulin dependent, according to Globes.
“We wanted to do more than just replace injections — we wanted to provide an alternative oral medication as an earlier treatment that can extend the second phase [of diabetes progression] and prevent patients from becoming insulin dependent,” Kidron told Israel21c. “That’s the revolution.”
Phase 2 clinical trials are scheduled to begin in the United States.
Oramed also has other diabetes medications in the pipeline, including one that will help balance blood sugar and control appetite—since many people with Type 2 diabetes are overweight.
"Good things come to those who wait, not to those who hesitate."
Recent GLUC News
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 12/07/2023 07:58:40 PM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM